Clinical Trial Update: Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients [NA]

View source ↗

Summary

A completed clinical trial studied the association between FGF-23 and parathyroid hormone in patients with end-stage renal disease undergoing dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: James B. Wetmore, MD | Conditions: End-Stage Renal Disease | NA | Status: COMPLETED